Colorimetric and visual determination of DNase I activity using gold nanoparticles as an indicator

详细信息    查看全文

• 作者：Yue He ; Fen Cheng ; Dai-Wen Pang ; Hong-Wu Tang
• 关键词：Deoxyribonuclease ; Enzyme activity assay ; Visual test ; Thrombin ; Cytochrome C ; Double ; stranded DNA ; Nucleoside monophosphates ; Drug screening ; Systemic lupus erythematosus ; Myocardial infarction
• 刊名：Microchimica Acta
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：184
• 期：1
• 页码：101-106
• 全文大小：
• 刊物类别：Chemistry and Materials Science
• 刊物主题：Nanochemistry; Nanotechnology; Characterization and Evaluation of Materials; Analytical Chemistry; Microengineering;
• 出版者：Springer Vienna
• ISSN：1436-5073
• 卷排序：184

文摘

Patients with prostate cancer and systemic lupus erythematosus exhibit reduced DNase I activity, and patients with myocardial infarction exhibit increased DNase I activity. So the assay of DNase I is of high importance. A colorimetric assay is described here for the determination of the activity of DNase. It is based on strand scission of dsDNA as catalyzed by DNase I. The products of digestion (nucleoside monophosphates) can better stabilize citrate capped AuNPs than dsDNA. In the absence of DNase I, the AuNPs aggregate in presence of NaCl and then display a blue color. In the presence of the analyte (DNase I), AuNPs do not aggregate but rather remain dispersed and display a red color. These findings were exploited to design a DNase I activity assay that is based on the measurement of ratio of absorbances at 520 nm (red) to 650 nm (blue). The detection limit for DNase I activity is found to be 7.1 U⋅L−1. In our perception, this assay has a large potential with respect to diagnoses of DNase I activity-related diseases and in drug screening.